Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to analyze Adobe, CRM & Service now

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor20 Feb 2026, 00:54 UTC
Video preview for Friends! In this video, I'm going to analyze Adobe, CRM & Service now
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis focuses on AI disruption risks for software stocks, highlighting Adobe (ADBE) and ServiceNow (NOW). Adobe's stock has seen a significant decline, with its P/E ratio dropping sharply due to AI-related concerns, though its core products like Photoshop and Creative Cloud remain strong, with Firefly offering a potential defense against AI threats. ServiceNow, despite a lower AI risk score and a falling stock price, shows strong fundamentals with consistent revenue growth and high customer retention. The CEO's recent share purchase and optimistic outlook suggest potential upside despite the current market sentiment. The valuation multiples for both companies are analyzed in the context of AI's impact.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.